ClinicalTrials.Veeva

Menu

Effect of the Natural Sweeteners Erythritol and Xylitol on Vascular Function in Obese Volunteers

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: E968-Erythritol
Dietary Supplement: E967-Xylitol

Study type

Interventional

Funder types

Other

Identifiers

NCT02821923
Poly Vasc

Details and patient eligibility

About

Sugar alcohols such as xylitol and erythritol are increasingly popular as sugar substitutes in the food industry and are also recommended to diabetic patients. Both substances are already in use in the food industry and are freely available. Since the 1970s, beneficial effects on oral health could be demonstrated as oral bacteria were influenced positively. A pilot study recently undertaken in the US (Flint N, 2014) has shown that diabetics profit from a daily intake of erythritol, as this natural sweetener enhances the elasticity of the blood vessels. In this trial, investigators aim to examine whether this effect can be found in a non-diabetic but obese cohort, and whether also xylitol improves vascular function.

Enrollment

42 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obese volunteers (BMI > 30kg/m2)
  • Aged 18- max. 55 years
  • Otherwise healthy.

Exclusion criteria

  • Known cardiovascular disease
  • Diabetes mellitus
  • Smoking and drug abuse
  • Arterial hypertension with antihypertensive treatment
  • Dyslipidaemia with statin therapy
  • Known chronic hepatic disease (NASH, hepatitis).
  • Known renal disease: kidney failure
  • Pregnancy
  • Chronical diseases of the gastrointestinal tract, history of gastrointestinal surgery with major changes to the gastrointestinal tract
  • Substance abuse, alcohol abuse.
  • Inability to follow procedures due to psychological disorders, dementia or insufficient knowledge of project language (German).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

42 participants in 3 patient groups

Control
No Intervention group
Description:
no treatment
E967-Xylitol
Active Comparator group
Description:
24g xylitol/d
Treatment:
Dietary Supplement: E967-Xylitol
E968-Erythritol
Active Comparator group
Description:
36g erythritol/d
Treatment:
Dietary Supplement: E968-Erythritol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems